title: [Current application of osteoporosis guidelines--expert recommendations of the German Society of Orthopaedic Surgery and Traumatology].
abstract: OBJECTIVE
  As an increasing number of patients suffer from osteoporosis-related disorders worldwide, the medical as well as the socioeconomic impact of this problem is significant. Although evidence-based guidelines for diagnosis and treatment are available, their application in daily practice is insufficient. The aim of our initiative was to develop a strategy for supporting this transfer.
  
  
  METHODS
  An expert group of the German Society of Orthopaedics and Traumatology (DGOU) has analysed the current scientific as well as health-care data bases regarding diagnosis and treatment of osteoporosis. Then a set of recommendations has been developed in order to improve this situation.
  
  
  RESULTS
  The identified support strategy will focus on better identification of patients with osteoporosis and frailty, enhanced interdisciplinary approaches and increased activity to disseminate available guidelines. Additionally, more research activities are necessary in order to highlight the socioeconomic burden of the disease and to continuously improve surgical treatment strategies in the future.
  
  
  CONCLUSIONS
  To ensure a successful application of the recommendations, continuous support of involved health professionals as well as political institutions, national health insurance systems, scientific societies and patient organisations is necessary.
authors.affiliation: Klinik und Poliklinik für Orthopädie, Universitätsklinikum Carl Gustav Carus Dresden. klaus-peter.guenther@uniklinikum-dresden.de
authors.forename: K-P
authors.initials: KP
authors.lastname: Günther
authors.forename: L
authors.initials: L
authors.lastname: Hofbauer
authors.forename: A
authors.initials: A
authors.lastname: Defer
authors.forename: K
authors.initials: K
authors.lastname: Dreinhöfer
authors.forename: G
authors.initials: G
authors.lastname: Duda
authors.forename: J
authors.initials: J
authors.lastname: Goldhahn
authors.forename: F
authors.initials: F
authors.lastname: Jakob
authors.forename: A
authors.initials: A
authors.lastname: Kurth
authors.forename: I
authors.initials: I
authors.lastname: Linde
authors.forename: M J
authors.initials: MJ
authors.lastname: Raschke
authors.forename: J M
authors.initials: JM
authors.lastname: Rueger
authors.forename: R
authors.initials: R
authors.lastname: Steinbronn
authors.forename: C
authors.initials: C
authors.lastname: Stroszczynski
authors.forename: L
authors.initials: L
authors.lastname: Unger
authors.forename: H
authors.initials: H
authors.lastname: Zwipp
mesh_terms: D000368:Aged; D050071:Bone Density Conservation Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis / Q000639:trends; D019033:Delivery of Health Care, Integrated / Q000191:economics / Q000458:organization & administration; D019317:Evidence-Based Medicine / Q000639:trends*; D005260:Female; D005544:Forecasting; D005598:Fractures, Spontaneous / Q000191:economics / Q000517:prevention & control; D005858:Germany; D019983:Guideline Adherence / Q000639:trends*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics
chemical_list: D050071:Bone Density Conservation Agents